HOME >> BIOLOGY >> NEWS
No serious adverse events found with next-generation smallpox vaccine

BALTIMORE, MD March 21, 2005 -- Interim data from a phase I/II clinical trial of a next-generation vaccine for smallpox suggest that the vaccine may provide immunity and thus far the trial has been without any serious adverse events. Researchers report their data today at the 2005 American Society for Microbiology Biodefense Research Meeting.

LC16m8 is a live attenuated smallpox vaccine that is produced in cell culture from vaccinia virus that has been attenuated, or modified, so that it can initiate an immune response without causing serious adverse effects. Derived from the Lister strain of vaccinia, LC16m8 has been licensed in Japan since 1980 and forms the basis of that country's national vaccine stockpile.

"The preliminary study results are consistent with the far larger Japanese experience," said Dr. Richard Greenberg of the Kentucky School of Medicine, and one of the researchers on the study. "LC16m8, an attenuated smallpox vaccine, has had a 100% take rate and has been well tolerated. Intensive monitoring for myopericarditis has not uncovered any cardiac toxicity in the first 66 volunteers."

"Take rate", or the percentage of vaccinees who form a pock at the site of injection, is a traditional measure of a smallpox vaccine's effectiveness in producing an immune response.

Currently, the only smallpox vaccine that has been licensed for use in the United States, Dryvax®, is made from unattenuated vaccinia virus, a relative of the smallpox virus. Serious side effects have been associated with this and other unattenuated smallpox vaccines, including potentially fatal encephalitis and heart inflammation.

The clinical trial represents the first clinical study of LC16m8 in the United States and is another step forward for VaxGen, Inc. towards its goal of introducing a safer, more effective smallpox vaccine to the United States. The interim data represent the pooled, blinded findings from the first 66 volunteers in the clinical trial.
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
21-Mar-2005


Page: 1 2

Related biology news :

1. Study warns deep-sea mining may pose serious threat to fragile marine ecosystems
2. Public agrees global warming exists, but divided over seriousness of problem
3. Drug-induced labor increases risk of rare but serious delivery complication
4. Research could lead to dramatic improvement in scanning for serious diseases
5. Cornell researchers find serious fish virus in Northeast for first time
6. New understanding of parasite cell structures may provide treatments for serious tropical diseases
7. Research suggests therapy against serious side effects of smallpox vaccine
8. Study discovers serious deficiencies in apparently normal heart valves
9. New AAAS report cites serious concerns with electronic voting
10. Joslin researchers pinpoint causes of adverse reactions to popular type 2 diabetes drugs
11. First analysis of FDAs mifepristone adverse event reports

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... 13, 2018 , ... Career fairs provide an ideal setting ... systems at once. However, healthcare professionals often have hectic schedules with little spare ... healthcare providers who wish to explore opportunities and learn about multiple employers from ...
(Date:8/14/2018)... , ... August 13, 2018 , ... ... products, the Staticmaster® P-2021-5502 and P-2021-5602 Cleanroom Ionizing Gun. , The ionizing ... Nitrogen Air Gun, P-2021 ionizing cartridge, 0.5-micron filter and electropolished OSHA-compliant tip. This ...
(Date:8/14/2018)... Fla. (PRWEB) , ... August 14, 2018 , ... ... activity and sleep monitoring solutions for the global scientific community, announced today the ... focus of this new division is to foster and support scientific collaborations with ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 08, 2018 , ... InTouchMD , the ... announced that they will be exhibiting at Biotech Week Boston , September 4th ... showcasing its Pulse platform, healthcare’s most powerful all in one marketing solution. ...
(Date:8/7/2018)... ... August 06, 2018 , ... Slone Partners, North America’s ... of Dr. Paul Harney as President, North America at Prescient Healthcare Group. Dr. ... client satisfaction. He was also named to Prescient’s Board of Directors. , ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... years, announces the launch of their new website. The new website has been ... the site. Mahoney partnered with Proceed Innovative to build a website created for ...
(Date:7/25/2018)... MATEO, Calif. (PRWEB) , ... July 25, 2018 ... ... for in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud approach ... Schaevitz, Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment of ...
Breaking Biology Technology:
Cached News: